| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Unmet need in chronic hepatitis B management
Lilian Yan Liang, Grace Lai-Hung Wong
Clin Mol Hepatol.2019;25(2):172-180.   Published online February 12, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0106
                              
KASL clinical practice guidelines for management of chronic hepatitis B
Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol.2019;25(2):93-159.   Published online June 12, 2019     
DOI: https://doi.org/10.3350/cmh.2019.1002
                              Supplementary      
Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kwang-il Kim, Soo-Hwan Kim, Kyu Sung Rim, Seong Gyu Hwang
Clin Mol Hepatol.2019;25(1):52-64.   Published online October 23, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0040
                                 Cited By 1
Favorable effect of corticosteroids in treating acute-on-chronic liver failure underlying chronic hepatitis B
Hyeji Kim, Jung Hyun Kwon, Yong Hee Kim, Soon Woo Nam, Jong Yul Lee, Jeong Won Jang
Clin Mol Hepatol.2018;24(4):430-435.   Published online November 27, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0016
                              
Characterization and evaluation of liver fibrosis grade in patients with chronic hepatitis B virus infection and normal transaminases
San Juan López Cristina, Casado Martín Marta, González Sánchez Mercedes, Porcel Martín Almudena, Hernández Martínez Álvaro, Vega Sáenz Jose Luis, Parrón Carreño Tesifón
Clin Mol Hepatol.2018;24(4):384-391.   Published online July 4, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0004
                                 Cited By 1
Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them
Kwang Il Seo, Si Hyun Bae, Pil Soo Sung, Chung-Hwa Park, Hae Lim Lee, Hee Yeon Kim, Hye Ji Kim, Bo Hyun Jang, Jeong Won Jang, Seung Kew Yoon, Jong Young Choi, In-Yang Park, Juyoung Lee, Hyun Seung Lee, Sa-Jin Kim, Jung Hyun Kwon, U Im Chang, Chang Wook Kim, Se Hyun Jo, Young Lee Young Lee, Fisseha Tekle, Jong-Hyun Kim
Clin Mol Hepatol.2018;24(4):374-383.   Published online June 26, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0082
                              
Assessment of fibrotic burden among chronic hepatitis B virus-infected patients with normal transaminase level
Mi Young Jeon, Beom Kyung Kim, Seung Up Kim
Clin Mol Hepatol.2018;24(4):367-369.   Published online September 19, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1008
                              
Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend
Grace Lai-Hung Wong
Clin Mol Hepatol.2018;24(2):108-113.   Published online January 22, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0068
                                 Cited By 4
Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B
Kwan Sik Lee, Young-Oh Kweon, Soon-Ho Um, Byung-Ho Kim, Young Suk Lim, Seung Woon Paik, Jeong Heo, Heon-Ju Lee, Dong Joon Kim, Tae Hun Kim, Young-Sok Lee, Kwan Soo Byun, Daeghon Kim, Myung Seok Lee, Kyungha Yu, Dong Jin Suh
Clin Mol Hepatol.2017;23(4):331-339.   Published online September 26, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0040
                                 Cited By 1
Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice?
Joon Yeul Nam, Jeong-Hoon Lee
Clin Mol Hepatol.2017;23(4):311-313.   Published online December 4, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0069
                              
Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir
Hee-Jeong Jeon, Seok Won Jung, Neung Hwa Park, Yujin Yang, Jin-Hee Noh, Jae-Sung Ahn, Hyung Rae Kim, Jae Ho Lee, Jung Woo Shin
Clin Mol Hepatol.2017;23(3):230-238.   Published online June 30, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0003
                                 Cited By 4
Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?
Yun Bin Lee, Jeong-Hoon Lee
Clin Mol Hepatol.2017;23(3):219-221.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0045
                              
Current status and strategies for hepatitis B control in Korea
Eun Ju Cho, Sung Eun Kim, Ki Tae Suk, Jihyun An, Soung Won Jeong, Woo Jin Chung, Yoon Jun Kim
Clin Mol Hepatol.2017;23(3):205-211.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0104
                                 Cited By 17
Current status and strategies for viral hepatitis control in Korea
Dong Hyun Sinn, Eun Ju Cho, Ji Hoon Kim, Do Young Kim, Yoon Jun Kim, Moon Seok Choi
Clin Mol Hepatol.2017;23(3):189-195.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0033
                                 Cited By 3
Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B
Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik
Clin Mol Hepatol.2017;23(2):170-178.   Published online May 16, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0086
                              Supplementary         Cited By 5
Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B
Hee Yeon Seo, Han Ah Lee, Soon Young Ko, Joon Ho Wang, Jeong Han Kim, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol.2017;23(2):154-159.   Published online May 8, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0067
                                 Cited By 2
Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis
Oidov Baatarkhuu, Hye Won Lee, Jacob George, Dashchirev Munkh-Orshikh, Baasankhuu Enkhtuvshin, Sosorbaram Ariunaa, Mohammed Eslam, Sang Hoon Ahn, Kwang-Hyub Han, Do Young Kim
Clin Mol Hepatol.2017;23(2):147-153.   Published online May 2, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0055
                                 Cited By 2
Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma
Mingkuan Su, Jianfeng Guo, Jiancheng Huang
Clin Mol Hepatol.2017;23(2):138-146.   Published online April 21, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0083
                                 Cited By 2
Is alanine aminotransferase flare-up in nucleos(t)ide analogue treatment of chronic hepatitis B a promising, rather than a devastating, sign?
Nae-Yun Heo
Clin Mol Hepatol.2017;23(2):125-127.   Published online June 23, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0106
                                 Cited By 1
Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients
Goh Eun Chung, Eun Ju Cho, Jeong-Hoon Lee, Jeong-ju Yoo, Minjong Lee, Yuri Cho, Dong Hyeon Lee, Hwi Young Kim, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Fabien Zoulim
Clin Mol Hepatol.2017;23(1):66-73.   Published online February 14, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0060
                                 Cited By 6
Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization
Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi
Clin Mol Hepatol.2016;22(4):458-465.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0054
                                 Cited By 2
Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
Hye Won Lee, Jun Yong Park, Beom Kyung Kim, Moon Young Kim, Jung Il Lee, Young Suk Kim, Ki Tae Yoon, Kwang-Hyub Han, Sang Hoon Ahn
Clin Mol Hepatol.2016;22(4):443-449.   Published online November 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0037
                                 Cited By 5
Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?
Byung-Cheol Song
Clin Mol Hepatol.2016;22(4):439-442.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0108
                              
New perspectives of biomarkers for the management of chronic hepatitis B
Chih-Lin Lin, Jia-Horng Kao
Clin Mol Hepatol.2016;22(4):423-431.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0069
                                 Cited By 21
Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B
Han Ah Lee, Yeon Seok Seo, Seung Woon Park, Sang Jung Park, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um
Clin Mol Hepatol.2016;22(3):382-389.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0047
                                 Cited By 4
Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment
Hong Joo Kim, Soo Kyung Park, Hyo Joon Yang, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi
Clin Mol Hepatol.2016;22(3):350-358.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0019
                              
Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park
Clin Mol Hepatol.2016;22(3):339-349.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0021
                                 Cited By 3
Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?
Byoung Kuk Jang
Clin Mol Hepatol.2016;22(3):336-338.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0104
                              
The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
Ioannis Varbobitis, George V. Papatheodoridis
Clin Mol Hepatol.2016;22(3):319-326.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0045
                                 Cited By 24
Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases
Hyeki Cho, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Kook-Hwan Oh, Kyoungbun Lee, Syifa Mustika, Jung-Hwan Yoon, Yoon Jun Kim
Clin Mol Hepatol.2016;22(2):286-291.   Published online June 25, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0066
                                 Cited By 3
1 | 2 | 3 | 4 | 5 | 6 | 7 |
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 413
TOTAL : 148527